Dr. Christina M. Jefferson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 202 Broadway, Davenport, OK 74026 Phone: 918-377-2239 Fax: 918-377-2236 |
News Archive
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will introduce the new DC-T6 ultrasound system at the annual Radiological Society of North America conference.
His Highness Sheikh Mohamed Bin Rashid Al Maktoum, Vice President, Prime Minister of UAE and Ruler of Dubai, announced plans to construct a state-of-the-art, specialized children's hospital with the highest international standards, in honour of his daughter, Her Highness Sheikha Jalila.
Allergan, Inc. today announced that the United States Food and Drug Administration has approved ZYMAXID (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms; Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group, Streptococcus oralis, Streptococcus pneumonia.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the U.S. District Court of the District of Massachusetts has ruled in favor of Alnylam and has denied Tekmira Pharmaceuticals Corporation's motion to dismiss certain claims and motion to disqualify Alnylam's counsel in an infringement suit filed in January 2012.
Biomira Inc. has announced publication of study results showing that Stimuvax, formerly known as BLP25 Liposome Vaccine or L-BLP25, could slow rising Prostate Specific Antigen (PSA) levels in some post-surgical prostate cancer patients
› Verified 2 days ago